Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS Care.
OBJECTIVE
Clinicians are increasingly challenged by presentation of morphologic and metabolic complications in HIV-infected patients. These complications are associated with HIV infection and/or combination antiretroviral therapy. This Consensus Statement is intended to offer guidance to clinicians actively involved in HIV/AIDS care.


METHODS
Seven clinicians with expertise in HIV medicine were invited by the International Association of Physicians in AIDS Care (IAPAC) to serve on an ad hoc Advisory Committee.


METHODS
IAPAC convened the Advisory Committee to develop a draft Consensus Statement. Each clinician was tasked with drafting a specific section of the Consensus Statement corresponding with his or her expertise around a morphologic and/or metabolic complication. Scientific and clinical research, and other data in published literature and abstracts from scientific conferences were considered by strength of evidence. This document represents the consensus agreement of the Advisory Committee.
Fichtenbaum
Carl J
CJ
Hadigan
Colleen M
CM
Kotler
Donald P
DP
Pierone
Gerald
G
Sax
Paul E
PE
Steinhart
Corklin R
CR
Tebas
Pablo
P
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008659:Metabolic Diseases / Q000150:complications / Q000628:therapy*
D019380:Anti-HIV Agents